Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LENVATINIB vs LEUPROLIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LENVATINIB vs LEUPROLIDE: Safety Overview

Metric LENVATINIB LEUPROLIDE
Total FAERS Reports 33,766 70,893
Deaths Reported 4,449 11,858
Death Rate 13.2% 16.7%
Hospitalizations 19,975 10,499
Average Patient Age 65.4 yrs 67.5 yrs
% Female Patients 55.8% 14.1%
FDA Approval Date Feb 13, 2015 Apr 14, 2023
Manufacturer Eisai Inc. TOLMAR Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Discontinued